The global bioprocess technology market reached USD 31.2 billion in 2024. IMARC Group projects it to grow at a CAGR of 6.65% from 2025 to 2033, reaching USD 55.7 billion by 2033. This growth is driven by advancements in biotechnology, increasing biopharmaceutical production, and rising demand for innovative therapeutic solutions. https://www.imarcgroup.com/bioprocess-technology-market